-Airway serous secretion is essential for the maintenance of mucociliary transport in airway mucosa, which is responsible for the upregulation of mucosal immunity. Although there are many articles concerning the importance of Tolllike receptors (TLRs) in airway immune systems, the direct relationship between TLRs and airway serous secretion has not been well investigated. Here, we focused on whether TLR5 ligand flagellin, which is one of the components of Pseudomonas aeruginosa, is involved in the upregulation of airway serous secretion. Freshly isolated swine tracheal submucosal gland cells were prepared, and the standard patch-clamp technique was applied for measurements of the whole cell ionic responses of these cells. Flagellin showed potentiating effects on these oscillatory currents induced by physiologically relevant low doses of acetylcholine (ACh) in a dose-dependent manner. These potentiating effects were TLR5 dependent but TLR4 independent. Both nitric oxide (NO) synthase inhibitors and cGMPdependent protein kinase (cGK) inhibitors abolished these flagellininduced potentiating effects. Furthermore, TLR5 was abundantly expressed on tracheal submucosal glands. Flagellin/TLR5 signaling further accelerated the intracellular NO synthesis induced by ACh. These findings suggest that TLR5 takes part in the airway mucosal defense systems as a unique endogenous potentiator of airway serous secretions and that NO/cGMP/cGK signaling is involved in this rapid potentiation by TLR5 signaling. Ca 2ϩ -activated Cl Ϫ channel; nitric oxide; cGMP-dependent protein kinase; patch-clamp; Pseudomonas aeruginosa TRACHEAL SUBMUCOSAL GLANDS secrete mucin, various enzyme proteins, and electrolytes (therefore, water), which serve as a nonspecific airway defense mechanism. Additionally, submucosal glands secrete immunoglobulins to neutralize many microbes, serving as a specific airway defense mechanism (34). Among these airway mucosal defense systems, airway serous secretion plays important roles in hydrating airway surfaces and flushing mucin glycoproteins out of the ducts, contributing to the maintenance of mucociliary transport (2, 4, 10, 24, 48) . Human, feline, and swine tracheal gland acinar cells generate ionic currents in response to relatively low doses of cholinergic and ␣-adrenergic stimuli, and these currents are activated by the intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) raised by these neurotransmitters (16, 31, 38, 44, 45) . The Ca 2ϩ -activated Cl Ϫ channel (CaCC) may play an important role in physiological basal secretions in the airways. It has recently become known that CaCC composes a newly identified transmembrane protein with unknown function, 16, Ano 1 (TMEM16A), which exists in both the airway surface epithelium and submucosal glands (28, 33) . Concerning the electrophysiological characteristics of CaCC, we have reported that tyrosine kinase, cyclic-ADP ribose, and nitric oxide (NO)/cGMP/cGMP-dependent protein kinase (cGK) are involved in the intracellular pathway of oscillatory ionic currents evoked by low doses of acetylcholine (ACh) (18, 39, 44) .
TRACHEAL SUBMUCOSAL GLANDS secrete mucin, various enzyme proteins, and electrolytes (therefore, water), which serve as a nonspecific airway defense mechanism. Additionally, submucosal glands secrete immunoglobulins to neutralize many microbes, serving as a specific airway defense mechanism (34) . Among these airway mucosal defense systems, airway serous secretion plays important roles in hydrating airway surfaces and flushing mucin glycoproteins out of the ducts, contributing to the maintenance of mucociliary transport (2, 4, 10, 24, 48) . Human, feline, and swine tracheal gland acinar cells generate ionic currents in response to relatively low doses of cholinergic and ␣-adrenergic stimuli, and these currents are activated by the intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) raised by these neurotransmitters (16, 31, 38, 44, 45) . The Ca 2ϩ -activated Cl Ϫ channel (CaCC) may play an important role in physiological basal secretions in the airways. It has recently become known that CaCC composes a newly identified transmembrane protein with unknown function, 16, Ano 1 (TMEM16A), which exists in both the airway surface epithelium and submucosal glands (28, 33) . Concerning the electrophysiological characteristics of CaCC, we have reported that tyrosine kinase, cyclic-ADP ribose, and nitric oxide (NO)/cGMP/cGMP-dependent protein kinase (cGK) are involved in the intracellular pathway of oscillatory ionic currents evoked by low doses of acetylcholine (ACh) (18, 39, 44) .
Toll-like receptors (TLRs) are known to be key proteins that recognize distinct pathogen-associated molecular patterns (PAMPs) and activate innate immune responses as well as antigen-specific adaptive immunity (1, 22) . It is also known that airway epithelial cells express several kinds of TLRs and that the activation of TLRs on epithelial cells induces the production of several cytokines, chemokines, and antimicrobial peptides (11, 12, 40) . In chronic inflammatory airway diseases like chronic obstructive pulmonary disease (COPD), Pseudomonas aeruginosa (P. aeruginosa) often colonizes the airway mucosal surface and sometimes causes repeated respiratory infections, resulting in exacerbations of these diseases (42) . P. aeruginosa involves LPS in its cell wall and flagellin in its flagellum, each of which are known to be a ligand for TLR4 and TLR5, respectively. We have recently shown that the TLR4 ligand functions as a unique, endogenous potentiator of serous secretion from tracheal gland acinar cells (31) . However, because LPS is known to be a prototypical example of endotoxin, it may cause nonspecific effects other than as a TLR4 ligand in vivo. On the other hand, although it has become increasingly clear that flagellin/TLR5 signaling plays an important role in the airway mucosal innate immunity systems (35) , it is not well known whether flagellin potentiates airway serous secretion.
Here, we investigated the potential role of flagellin in serous secretion from tracheal submucosal glands. Flagellin potentiated the electrolyte secretion from tracheal gland acinar cells, and its potentiating effect was reproduced only when cells were stimulated by physiologically relevant low doses of ACh. The intracellular mechanism of this rapid action appeared to be induced by both NO and cGK. These potentiating effects induced by flagellin were TLR5 dependent but TLR4 independent. Flagellin caused a significant potentiation in ACh-induced intracellular NO synthesis, which was almost abolished by treatment with anti-TLR5 blocking antibody. These findings suggest that TLR5 is also involved in the airway mucosal defense systems as a unique endogenous potentiator of electrolyte-water secretion from submucosal gland acinar cells and that NO/cGMP/cGK signaling is involved in this rapid TLR5 signaling pathway.
MATERIALS AND METHODS
Preparation of cells. Swine tracheas were obtained at a local slaughterhouse immediately after the animals had been killed and were transported to our laboratory in an ice-cold extracellular solution. The external surfaces of tracheas were cleaned of fat and connective tissues and cut into rings 3-4 cm long. The posterior (membranous) strip of tracheal walls were then excised longitudinally, leaving attached to both sides a cartilaginous portion of about 1 cm in width, and were fixed by pins in the extracellular solution with the external wall side up. The outermost layer and thick smooth muscle layer were carefully removed. The submucosal glands could then be easily distinguished from the surrounding connective tissue under a stereoscopic microscope with the light shed horizontally. Fresh, unstained submucosal glands were isolated using two pairs of tweezers and microscissors. The isolated glands were further dispersed enzymatically by incubating them with enzyme solution containing collagenase (200 U/ml) and DL-DTT (0.31 mg/ml) for 30 min at 37°C. After dispersion and a wash with centrifugation at 180 g, the cells were resuspended in a standard extracellular solution until use, as reported previously (16, 17, 31, 38, 39, 44, 45) . In a series of experiments investigating the effect of blocking antibodies, anti-TLR 5 polyclonal antibody (10 g/ml) or nonspecific IgG (10 g/ml) was also preincubated with cells for 1 h at 37°C before use.
Electrical recordings. Ionic currents were measured with a patchclamp amplifier (EPC9; HEKA Electronic, Lambrecht, Germany), low-pass filtered at 2.9 kHz, and monitored on both a built-in software oscilloscope and a thermal pen recorder (RECTI-HORIZ-8K; Nippondenki Sanei, Tokyo, Japan). Patch pipettes were made of borosilicate glass capillary with an outer diameter of 1.5 mm using a vertical puller (PP-83; Narishige Scientific Instruments, Tokyo, Japan) and had a tip resistance of 4 -6 M⍀. The junction potential between the patch pipette and bath solution was nulled by an amplifier circuitry. After the establishment of a high-resistance (1 G⍀), tight seal, the whole cell configuration was obtained by rupturing the patch membrane with negative pressure applied to the pipette tip. Membrane currents were monitored at two different holding potentials (Hps), i.e., 0 and Ϫ80 mV, which roughly corresponded to the Cl Ϫ and K ϩ equilibrium potential. The double current monitoring, i.e., alternate recording of the ionic currents corresponding to Hp of 0 and Ϫ80 mV, was accomplished by applying 200-ms voltage pulses of Ϫ80 mV at a frequency of 2 Hz to the pipette voltage of 0 mV (16, 17, 31, 38, 39, 44, 45 (16, 17, 31, 38, 39, 44, 45) . The solutions included an extracellular (bath) solution of 120 mM NaCl, 4.7 mM KCl, 1.13 mM MgCl 2, 1.2 mM CaCl2, 10 mM glucose, and 10 mM HEPES and an intracellular (pipette) solution of 120 mM KCl, 1.13 mM MgCl 2, 0.5 mM EGTA, 1 mM Na2ATP, 10 mM glucose, and 10 mM HEPES. The fluids were superfused over the cells by hydrostatic pressure-driven application (20 -30 cmH2O) through polyethylene tubes. All solutions were at pH 7.2, and all experiments were carried out at room temperature (22-25°C) .
Quantification procedure. The procedure to estimate the ionic responses was also applied in our previous reports (17, 31, 44, 45) . We first measured the area circumscribed with the current trace (I o or Ii) and baseline for 20 s (area under curve20) by using a digital planimeter (PLACOM, KP-92N; Koizumi, Tokyo, Japan). This area shows the net electric charge movements of 20-s duration in each condition. The mean magnitudes of ionic currents for 20 s were next expressed by the following calculation: I mean ϭ area under curve20/20 (pQ/s).
The effect of flagellin on the ACh-stimulated response was estimated by comparing data just before and after treatment with flagellin and was expressed as a percentage of pretreatment control values: %I mean(ACh ϩ flagellin) ϭ [Imean(ACh ϩ flagellin)/Imean(ACh)] ϫ 100. The effect of cGK inhibitor on the responses induced by both ACh and flagellin was expressed as a percentage of I mean(ACh ϩ cGK inhibitor). %I mean(ACh ϩ flagellin ϩ cGK inhibitor) ϭ [Imean(ACh ϩ flagellin ϩ cGK inhibitor)/I mean(ACh ϩ cGK inhibitor)] ϫ 100. In some experiments, cGK inhibitor was replaced by NO synthase (NOS) inhibitors.
Immunofluorescent staining. After the swine were killed, fresh trachea or spleen blocks were prepared and cut into sections that were 3 mm ϫ 10 mm. Tissue blocks were fixed by 10% buffered formalin and embedded in paraffin wax. The slides were heated in an autoclave at 121°C for 15 min in 0.1% sodium azide solution (pH 9.0; Nichirei, Tokyo, Japan) after deparaffinization for antigen retrieval. The sections (2.5-m thickness) were incubated for 10 min with Protein Block Serum-Free (Dako, Carpenteria, CA) at room temperature to block nonspecific binding sites. After removal of the blocking solution, these sections were incubated with a rabbit polyclonal anti-TLR5 Ab specific to a 300 -350-amino-acid residue (IMG-580, diluted 1:100; IMGENEX, San Diego, CA) overnight at 4°C, as described previously (31) . Antibody localization was performed using the DAKO EnVision/AP (Dako, Glostrup, Denmark) in darkness at room temperature for 50 min. Negative control samples were incubated with the secondary antibody only. The reaction was then completed with a substrate system using Permanent Red (Dako) as the chromogen. Sections were mounted in Slow Fade Antifade kit (Invitrogen, Carlsbad, CA) with DAPI (9) .
Western blotting. Swine tracheal submucosal glands were lysed in RIPA buffer containing protease inhibitor cocktail and phosphatase inhibitor cocktail (Sigma-Aldrich, St. Louis, MO) and centrifuged at 15,000 g for 30 min at 4°C. Proteins were separated by SDS-PAGE (Novex 12% Tris-glycine) and transferred onto PVDF using iBlot (Invitrogen). Membranes were then blocked with PVDF Blocking Reagent for Can Get Signal (Toyobo, Osaka, Japan), immunoblotted with a rabbit polyclonal anti-TLR5 Ab (IMG-580, IMGENEX) diluted with Can Get Signal Immunoreaction Enhancer Solution 1 (Toyobo) for 1 h at room temperature followed by the relevant horseradish peroxidase-conjugated secondary antibodies (Santa Cruz Biotechnology, Santa Cruz, CA) diluted with Can Get Signal Immunoreaction Enhancer Solution 2 (Toyobo) for 1 h at room temperature. The signals were visualized using the ECL detection system (GE Healthcare, Piscataway, NJ).
RT-PCR. Total RNA was isolated from swine tracheal submucosal gland cells and from swine spleen tissue as a positive control with an RNeasy Mini kit (QIAGEN, Tokyo, Japan). All cDNA was prepared by reverse transcription from 1 g of total RNA, using oligo(dT)20 primer and Superscript III reverse transcription (Invitrogen). The oligonucleotide primers used in PCR were as follows: swine TLR5 sense, 5=-TTT CTG GCA ATG GCT GGA CA-3=; antisense, 5=-TGG AGG TTG TCA AGT CCA TG-3=; swine ␤-actin sense, 5=-CAT CAC CAT CGG CAA CGA-3=; antisense, 5=-GCG TAG AGG TCC TTC CTG ATG T-3=. The PCR cycling conditions were 3 min at 94°C, followed by 35 cycles of 30 s at 94°C, 30 s at 60°C, and 30 s at 72°C. DNA fragments were analyzed in a 2% agarose gel electrophoresis.
Intracellular NO imaging with diaminofluorescein-2 diacetate. A highly specific fluorescent NO indicator, 4,5-diaminofluorescein (DAF-2), is known to be useful to estimate the amount of NO produced in the cytosol (25) . The diacetate salt DAF-2DA is membrane permeable and is soon hydrolyzed at the ester bonds by the intracellular esterase, resulting in the membrane impermeable and relatively nonfluorescent compound, DAF-2. In the presence of oxy-gen, NO combines with DAF-2 and forms the highly fluorescent triazolofluorescein DAF-2T. Peak excitation and emission wavelengths for DAF-2T occur at 495 and 515 nm, respectively. The fluorescence intensity shows a linear correlation with the concentration of DAF-2T, which is in parallel with the cellular production of NO. We have reported that freshly isolated swine tracheal glands showed good fluorescent responses with 10 M DAF-2DA (31, 44) . All experiments were carried out under the same conditions. To prevent the fluorescence signaling from becoming attenuated, the fluorescence intensity was measured for 5 s every 5 min. The solutions were the same compositions as used in the patch-clamp experiments (see Electrical recordings) and were gassed with 100% O 2 during the measurements. The green levels in the areas of gland cells in the captured microfluorographs were determined by digital image software (NIS-Elements Basic Research version 3.00; Nikon, Tokyo, Japan). Thus we detected the increase in the amount of intracellular NO per unit area of gland acini at each measurement time. NO production was estimated as fold increases over the basal fluorescence intensity. The fluorescence intensities in Statistics. Data were expressed as means Ϯ SE; n is the number of experiments on different cells. Electrophysiological experiments were analyzed by the Wilcoxon signed rank test. NO imaging experiments were analyzed by the Mann-Whitney U-test. Statistical significance was accepted at P Ͻ 0.05, indicated by asterisks in all figures.
Reagents. HEPES was purchased from Dojindo. DAF-2DA was from Sekisui Medical (Tokyo, Japan). N-monomethyl-L-arginine acetate (L-NMMA) and collagenase were from Wako Pure Chemicals (Osaka, Japan). Flagellin and LPS-Rhodobacter Sphaeroides (LPS-RS) were from InvivoGen (San Diego, CA). KT-5823, Rp-8-BrcGMP, and N6-(1-iminoethyl)-L-lysine hydrochloride (L-NIL) were from Calbiochem (La Jolla, CA). A goat polyclonal anti-TLR5 blocking antibody specific to a 151-181-amino-acid residue that is a part of extracellular epitopes and is known to be one of the flagellin-binding domains (8, 15, 50) was from Enzo Life Sciences International (Farmingdale, NY). A goat-nonspecific IgG was from R&D Systems (Minneapolis, MN). A rabbit polyclonal anti-TLR5 Ab (IMG-580) specific to 300 -350-amino-acid residue, which is a part of extracellular and flagellin-binding domains (7, 15) , was purchased from IMGENEX and used for both the immunofluorescence and Western blotting. All other chemicals used were purchased from Sigma.
RESULTS

Potentiating effects of flagellin on ACh-induced ionic currents.
We used flagellin as a ligand for TLR5. As mentioned in our previous reports ( (Fig. 1B) . However, 0.1 g/ml of flagellin showed no effect on both ACh (30 nM)-evoked I o (169.5 Ϯ 40.1 pQ/s for ACh and 168.0 Ϯ 40.0 for ACh/flagellin 0.1 , P ϭ 0.87; n ϭ 8) and I i (14.1 Ϯ 3.3 vs. 14.8 Ϯ 3.7 pQ/s, P ϭ 0.86; n ϭ 8) (Fig. 1C) . Flagellin (1.0 g/ml) per se was without effect on the baseline currents from nonstimulated resting cells (n ϭ 6) (Fig. 1D) . Remarkably, 1.0 g/ml of flagellin combined with 10 nM of ACh could generate oscillatory responses, such as those induced by 30 nM of ACh (Fig. 1E) . Data summarizing the effects of flagellin on the ionic currents evoked by 30 nM of ACh are shown in Fig. 1F .
When cells were stimulated by very high concentrations (1 M) of ACh, they were desensitized, and flagellin no longer showed any potentiation of the ionic currents (Fig. 1G) . It is suggested that flagellin can potentiate ionic currents only when the cells are moderately stimulated by low doses of ACh but not by physiologically irrelevant, robust concentrations of ACh. Intracellular calcium assays revealed that flagellin (1.0 g/ml) did not further increase the [Ca 2ϩ ] i in ACh (30 nM)-treated cells (Fig. 2) . These findings suggest that flagellin potentiates the ionic responses induced by the physiologically relevant dose (30 nM) of ACh in a dose-dependent manner without any increase in [Ca 2ϩ ] i and that these potentiating effects would be due to the increased sensitivity of NOS to [Ca 2ϩ ] i signaling. Importance of the interaction between flagellin and TLR5 in these potentiating effects. It has been reported that LPS shows the same potentiating effects as described above via the activation of TLR4 (31) . To confirm the importance of the interaction between flagellin and TLR5 but not TLR4, we investigated the effects of an anti-TLR5 blocking antibody and a specific TLR4 antagonist. When cells were pretreated with 10 g/ml of goat anti-human TLR5 blocking antibody (anti-TLR5 Ab), the potentiating effects by flagellin on both the ACh (30 nM)-evoked I o (169.5 Ϯ 41.0 pQ/s for ACh/antiTLR5Ab and 175.8 Ϯ 39.8 for ACh/antiTLR5Ab/flagellin, P ϭ 0.34; n ϭ 8) and I i (28.1 Ϯ 6.9 pQ/s vs. 32.0 Ϯ 8.3, P ϭ 0.08; n ϭ 8) were completely abolished (Fig. 3A) . Goat-nonspecific IgG (10 g/ml) did not have any inhibitory effects on the flagellininduced potentiations (I o : 126.0 Ϯ 33.2 pQ/s for ACh and 171.9 Ϯ 43.0 for ACh/flagellin, P Ͻ 0.05; n ϭ 6, I i : 29.2 Ϯ 5.0 vs. 38.5 Ϯ 6.1 pQ/s, P Ͻ 0.05; n ϭ 6) (Fig. 3B) . When cells were pretreated with LPS-RS (10 g/ml), a specific TLR4 antagonist, flagellin still showed a significant potentiating effect on both ACh (30 nM)-evoked I o and I i to 1.5-fold (101.8 Ϯ 24.8 pQ/s for ACh and 141.1 Ϯ 29.1 for ACh/flagellin, P Ͻ 0.05; n ϭ 7) and 1.3-fold (12.5 Ϯ 2.7 vs. 17.9 Ϯ 4.8 pQ/s, P Ͻ 0.05; n ϭ 7), respectively (Fig. 3C) . Conversely, anti-TLR5 Ab did not have any inhibitory effects on the LPS-induced potentiations (I o : 89.8 Ϯ 17.7 pQ/s for ACh and 143.0 Ϯ 25.5 for ACh/LPS, P Ͻ 0.05; n ϭ 8, I i : 25.0 Ϯ 2.0 vs. 35.2 Ϯ 2.3 pQ/s, P Ͻ 0.05; n ϭ 8) (Fig. 3D) . As summarized in Fig. 3E , the maneuvers to block the interaction between flagellin and TLR5 completely abolished the potentiating effects of flagellin on the ACh (30 nM)-evoked ionic currents. Flagellin-induced potentiations were not inhibited by LPS-RS, and LPS-induced potentiations were not inhibited by anti-TLR5 Ab (Fig. 3F) . These findings suggest that the interaction between flagellin and TLR5 is essential for the potentiating effects described above and that cross reactions between flagellin and TLR4 were not involved in these potentiations. ]i. Moreover, we found that physiologically relevant, basic secretions from swine tracheal submucosal glands could be triggered by ϳ30 nM of ACh (16, 17, 31, 38, 39, 44, 45) . The viability of all tested cells was confirmed by the occurrence of ionic responses after the subsequent addition of 30 nM of ACh. A: 1.0 g/ml of flagellin rapidly and significantly increased ACh (30 nM)-evoked Io and Ii. B: 0.5 g/ml of flagellin slightly but significantly increased ACh (30 nM)-evoked Io and Ii. C: 0.1 g/ml of flagellin did not cause any effects on either ACh (30 nM)-evoked Io or Ii. D: flagellin (1.0 g/ml) per se did not cause appreciable effects on the baseline currents in submucosal gland cells, whose viability was confirmed by the response to the subsequent addition of ACh (30 nM). E: 1.0 g/ml of flagellin generated oscillatory responses even under the presence of as low as 10 nM of ACh, which appeared to be insufficient to generate ionic channels. F: summary of the potentiating effects of flagellin on ACh (30 nM)-evoked Io and Ii. The electric charge movements of 20-s duration just before and after the introducing flagellin were compared by estimating the mean values of the ACh responses as 100% to exclude artifacts from differences in the membrane capacitance in each cell. Flagellin potentiated the ACh-evoked ionic currents in a dose-dependent manner, and these potentiating effects were significant only in the cases with 0.5 g/ml of flagellin or more. *P Ͻ 0.05. G: robust stimulation by as high as 1 M of ACh generated large and transient currents. However, even in the presence of ACh (1 M), these currents were spontaneously decreased, which is known as desensitization (data not shown). In the same condition, flagellin no longer showed potentiating effects on these large currents.
Abundant expression of TLR5 on swine tracheal submucosal glands. Immunofluorescent staining and RT-PCR experiments were performed using swine tracheal specimens to confirm the expression of TLR5. As a positive control, the specimen of swine spleen was evaluated in the same way. In the immunofluorescent experiments, strong red-positive fluorescence was observed in tracheal submucosal gland cells as well as ciliated epithelial cells located on the surface of trachea (Fig. 4, A-D) . RT-PCR also revealed a clear band corresponding to TLR5 in the product from cDNA of swine tracheal submucosal gland acinar cells (Fig. 4E) . Western blotting analysis further confirmed the expression of TLR5 in swine tracheal submucosal gland cells (Fig. 4F) . These findings indicate that TLR5 is certainly expressed on tracheal gland acinar cells at both the protein and mRNA levels.
Mechanisms underlying the flagellin-induced potentiation of triggered ionic currents in submucosal gland. A relationship between flagellin/TLR5 and NO/cGMP/cGK signaling has been suggested in some reports (26, 30) . Additionally, we have also reported that LPS-induced rapid activation of TLR4 involved NO/cGMP/cGK signaling (31) . Therefore, we investigated whether NO/cGMP/cGK signaling was involved in the present flagellin-induced potentiation. We used two different nonspecific NOS inhibitors, nitro-L-arginine methyl ester (L-NAME) and L-NMMA. In the presence of L-NAME (1 mM), flagellin did not show any potentiating effects on either the ACh (30 nM)-evoked I o (172.3 Ϯ 43.0 pQ/s for ACh/L-NAME and 167.0 Ϯ 42.1 for ACh/L-NAME/flagellin, P ϭ 0.61; n ϭ 7) or I i (37.5 Ϯ 10.9 vs. 42.0 Ϯ 12.3 pQ/s, P ϭ 0.17; n ϭ 7) (Fig. 5A) . L-NMMA (1 mM) also completely abolished the flagellin-induced potentiating effects on both the ACh (30 nM (Fig. 5C ). As summarized in Fig. 5F , nonspecific NOS inhibitors completely abolished the flagellin-induced potentiating effects, but the iNOS inhibitor did not. These findings suggest that constitutive NOS, not iNOS, is involved in the TLR5-mediated rapid potentiating effects on the tracheal gland secretion.
We next investigated the involvement of cGK by using two different types of cGK inhibitors, KT-5823 and Rp-8-BrcGMP. Under the pretreatment with 1 M of KT-5823, flagellin did not show any potentiating effect on either the ACh (30 nM)-evoked I o (84.4 Ϯ 21.6 pQ/s for ACh/KT5823 and 97.9 Ϯ 24.5 for ACh/KT5823/flagellin, P ϭ 0.09; n ϭ 6) or I i (15.6 Ϯ 5.3 vs. 17.7 Ϯ 7.1 pQ/s, P ϭ 0.37; n ϭ 6) (Fig. 5D ). Rp-8-Br-cGMP (5 M) also completely abolished the potentiating effect by flagellin on both the ACh (30 nM)-evoked I o (50.9 Ϯ 11.7 pQ/s for ACh/Rp8BrcGMP and 57.1 Ϯ 14.1 for ACh/Rp8BrcGMP/flagellin, P ϭ 0.09; n ϭ 7) and I i (14.3 Ϯ 4.5 vs. 15.1 Ϯ 5.7 pQ/s, P ϭ 0.34; n ϭ 7) (Fig. 5E ). As summarized in Fig. 5G , cGK inhibitors completely abolished the potentiating effects by flagellin. These findings suggest that the TLR5 ligand-mediated potentiation of triggered ionic currents in tracheal submucosal gland is closely related to the activation of NO/cGMP/cGK pathway.
Further upregulation in intracellular NO synthesis by flagellin on ACh-treated cells.
To address the possibility that flagellin activates TLR5, upregulates intracellular NO synthesis, and potentiates the ACh-triggered ionic currents, we investigated whether flagellin has the ability to upregulate the synthesis of NO in tracheal gland cells. The intracellular NO synthesis was estimated using DAF-2DA, a highly specific fluorescent NO indicator as described in our previous reports (31, 44) . Representative fluorescence micrographs of tracheal gland acini are shown in Fig. 6 , A-E. Unstimulated control cells did not show any increases in the green fluorescence signals during the 40-min observation (Fig. 6A) . On the other hand, cells stimulated by ACh (30 nM) showed slightly increased fluorescence intensities (Fig. 6B) . Flagellin (1.0 g/ml) in combination with ACh (30 nM) caused significantly stronger increases in the fluorescence intensities than ACh (30 nM) alone (Fig. 6C) . Interestingly, when cells were preincubated with 10 g/ml of anti-TLR5 Ab, the fluorescence intensities under the presence of both flagellin (1.0 g/ml) and ACh (30 nM) were at almost the same levels as those under the presence of ACh (30 nM) alone (Fig. 6D) . Moreover, the cells stimulated by flagellin (1.0 g/ml) alone showed slightly increased fluorescence intensities (Fig. 6E) . A summary of the changes in the time courses is shown in Fig. 6F . Fluorescence intensities were calculated by measuring the intensities per unit area from the cytosol and were compared by estimating mean intensities of prestimulation (0 min) as 1.0. Under the stimulation by flagellin (1.0 g/ml) in combination with ACh (30 nM), the fluorescence intensities increased more rapidly and strongly than in cells stimulated by ACh alone. However, these significant increases in the fluorescence intensities were completely abolished in the presence of anti-TLR5 Ab, and these intensity curves were at almost the same levels as those stimulated by ACh (30 nM) alone. These findings are in line with electrophysiological experiments (see Fig. 1F and 3E ). When the fluorescence intensities were estimated at 10 min, flagellin (1.0 g/ml) significantly increased the ratio in intensities up to 1.2-fold compared with ACh (30 nM)-stimulated cells (1.04 Ϯ 0.02 for ACh-stimulated value; n ϭ 7, and 1.24 Ϯ 0.04 for ACh/ flagellin-stimulated value; n ϭ 9, P Ͻ 0.05) (Fig. 6G) . These upregulations in NO syntheses were almost completely abolished under the presence of anti-TLR5 Ab (Fig. 6G) . These findings suggest that interaction between flagellin and TLR5 significantly upregulates the NO synthesis, contributing to the potentiating effect on electrolytes secretion from tracheal gland cells under physiologically relevant stimulation by ACh (30 nM).
DISCUSSION
In chronic inflammatory airway diseases such as COPD, P. aeruginosa often colonizes the airway mucosal surface and appears to have a role in the persistent inflammation or hypersecretion in the airways that results in repeated exacerbations in these diseases (42) . However, the exact reason why P. aeruginosa is closely related to hypersecretion is still not well understood. We considered that PAMPs might be involved. Both P. aeruginosa flagellin and LPS are PAMPs recognized by host pathogen-recognition receptors, TLR4 and TLR5, respectively (1). We have reported that LPS derived from P. aeruginosa caused significant potentiating effects on airway serous gland secretion via the activation of TLR4 (31). Be- cause LPS is known to be a prototypical example of endotoxin, it might cause nonspecific effects other than as a TLR4 ligand in vivo. In the present study, we focused on the function of TLR5 as another possible potentiator of airway serous secretion. Flagellin significantly potentiated Cl Ϫ secretion from freshly isolated tracheal submucosal gland acinar cells in a dose-dependent manner, and its potentiating effect was reproduced only when the cells were stimulated by physiologically relevant low doses of ACh (30 nM) (basal secretion) but not by robust doses of ACh (1 M) (experimental maximum stimulation). Flagellin significantly increased the ACh-induced intracellular NO synthesis, and NO/cGMP/cGK signaling was involved in this rapid potentiation by flagellin/TLR5. Additionally, our studies presented here showed the absence of any interaction between the flagellin/TLR5 signaling and LPS/ TLR4 signaling because the flagellin-induced potentiations were not inhibited by LPS-RS and the LPS-induced potentiations were not inhibited by anti-TLR5 Ab (Fig. 3F) . Combined with our previous report (31), these findings suggested that both TLR4 and TLR5 are endogenous potentiators of serous secretion from tracheal submucosal gland acinar cells and are likely to play important roles in the pathogenesis of airway hypersecretion in chronic P. aeruginosa infection. Concerning the concentration of flagellin, Yu and colleagues (51) reported that flagellin (0.1-10.0 g/ml) upregulated MUC5AC expression by activating TLR5 on 16HBE cells, but 0.01 g/ml of flagellin did not (51). Illek and colleagues (14) reported that flagellin (0.1-1.0 g/ml) activated p38, NF-B, IL-8, and cystic fibrosis transmembrane conductance regulator (CFTR)-dependent airway secretion in Calu-3 cells. These reports are in line with ours. However, other reports showed that as low as 50 -200 ng/ml of flagellin significantly upregulated IL-8 production and IL-23 production in airway epithelial cells (41) and intestinal dendritic cells (23) , respectively. We do not have a clear explanation for these differences, but we suppose that submucosal gland cells need a relatively high concentration of flagellin to potentiate airway secretion in vitro; otherwise they need carrier proteins or something to enhance the effects of flagellin in vivo. In the airway mucosal innate immunity system, the importance of flagellin/TLR5 signaling has become increasingly clear (35) . Actually, it was reported that flagellin derived from P. aeruginosa caused significant expression changes in hundreds of different genes, including the cytokines IL-8, IL-1␤, and TNF-␣, as well as genes associated with antibacterial factors and NF-B signaling in human nasal cystic fibrosis epithelial cells (13) . Additionally, it has also been reported that flagellin/TLR5 signaling induced MUC5AC overproduction via Duox2/ROS/TACE/TGF-␣/EGFR signaling cascade in cultivated 16HBE cells (51) . Both reports focused on the pathophysiological significance of flagellin/TLR5 signaling and mucus overproduction in chronic P. aeruginosa infections. We also showed the abundant expression of TLR5 on, not only tracheal submucosal gland cells, but also ciliated epithelial cells on the surface of trachea (Fig. 4B) . These findings are likely to indicate that flagellin/TLR5 signaling in ciliated epithelial cells also plays an important role in airway defenses. Indeed, P. aeruginosa infection with mucus overproduction in the airway is a leading cause of morbidity and mortality in patients with chronic inflammatory airway diseases, such as severe COPD and cystic fibrosis. However, airway serous secretion is also important for hydrating airway surfaces and flushing mucin glycoproteins out of the ducts, resulting in the upregulation of mucociliary transport (2, 4, 10, 24, 48) . There are many reports concerning the role of TLR5 in the airway mucus secretion, but those in serous secretion are quite limited in number (14, 27) . Kunzelmann and colleagues (27) reported that flagellin inhibited Na ϩ absorption by the epithelial Na ϩ channel without an elevation in [Ca 2ϩ ] i and might promote mucociliary clearance of pathogens in airway epithelia (27) . Because human airway epithelium is likely to be primarily absorptive (6, 18, 48) and because a major fraction of the airway fluid appears to be derived from the submucosal glands (3, 20, 28, 37) , we think it is rather important to understand the effects of flagellin/TLR5 signaling on Cl Ϫ secretion from submucosal glands. Notably, Illek and colleagues (14) 
NF-B, IL-8, and CFTR-dependent Cl
Ϫ secretion without altering the tight-junction permeability in Calu-3 cells, a serous-like cell line. They mentioned that, during P. aeruginosa infection, flagellin could be expected to increase CFTR-dependent Cl Ϫ secretion and promote bacterial clearance from the airways. Indeed, these conclusions are basically in line with ours, but there are several fundamental differences between their report and ours. First, we focused on Ca 2ϩ -dependent Cl Ϫ secretion, not cAMP/CFTR-dependent Cl Ϫ secretion. Second, flagellin itself did not cause any ionic currents in our experiments. Third, the flagellin-induced potentiating effect was reproduced only when the cells were weakly stimulated by physiologically relevant low doses of ACh (30 nM) but not by robust doses of ACh (1 M) in our experiments. At present, we do not have a clear explanation for these discrepancies, but they could be due to differences between freshly isolated gland cells and cultivated epithelial cell lines and also those between CaCC and CFTR.
Generally, it is known that there are two major pathways in the Cl Ϫ secretion from tracheal submucosal glands. One is characterized by the CFTR Cl Ϫ channel, which is mainly activated by cAMP; the other is characterized by CaCC. However, these increases in the fluorescence intensities were completely abolished under the presence of anti-TLR5 Ab, and the intensity curves were almost at the same levels as those when stimulated by ACh alone. n ϭ 7, *P Ͻ 0.05 to ACh alone. n ϭ 6, †P Ͻ 0.05 to ACh/flagellin/antiTLR5Ab. G: summary of the increases in fluorescence intensities of each indicated stimulation at 10 min after measurement. Flagellin (1.0 g/ml) significantly increased the intensities up to 1.2-fold compared with ACh (30 nM)-stimulated cells, but these upregulations were completely abolished under the presence of anti-TLR5 Ab. n ϭ 7, *P Ͻ 0.05 to ACh alone. n ϭ 6, †P Ͻ 0.05 to ACh/flagellin/antiTLR5Ab. Indeed, Vaadnrager and colleagues (47) (17, 38, 39) . Additionally, we have reported that maneuvers anticipating a rise in cAMP failed to potentiate and rather decreased ionic currents in tracheal gland cells (45) . These findings suggest that the Cl Ϫ currents observed in our experiments are due mainly to CaCC, not the CFTR Cl Ϫ channel. However, our considerations do not mean to exclude the involvement of CFTR in airway defenses. Further investigations will be needed to make it clear in the future. Concerning the importance of CaCC, it is noteworthy that TMEM16A has recently been identified as an essential component of Ca 2ϩ -dependent Cl Ϫ secretion and widely exists in the airway surface epithelium and submucosal glands (28, 33) . Additionally, it was also reported that human, swine, and ferret tracheal submucosal glands respond much more strongly to cholinergic stimulants than to other agents (19, 20, 49 ). An in vivo study has also demonstrated that cholinergic agents were much more potent stimulators of gland secretion than were adrenergic agonists, as ascertained by the hillock formations from a powdered tantalum layer coating the airway surface (32) . Furthermore, it was reported that Ca 2ϩ -dependent Cl Ϫ secretion is upregulated as a compensation mechanism in cystic fibrosis airways, where cAMP-dependent Cl Ϫ secretion is completely attenuated (29) . From these considerations, we believe that CaCC must be very important in the physiological basal airway secretion, which is stimulated by vagal nerve tonus in vivo. As shown in previous reports (16, 17, 31, 38, 39, 44, 45) , the airway basic serous secretion could be carried by intracellular calcium oscillations induced by physiologically relevant, low concentrations of ACh (30 nM) on freshly isolated tracheal submucosal glands. In the case of cultivated cells, strong stimulation by a considerably high dose of the agonist would be needed to obtain electrophysiological responses. However, we have also shown that excessively robust stimulation by ACh (300 nM or more) caused desensitization and that the cells did not respond to further stimulations in the case of freshly isolated cells (17, 31, 44, 45) . One of our experimental advantages is that we are able to detect the basal secretions as delicate oscillatory ionic currents induced by very low concentrations of ACh and investigate the effects of various physiological exogenous regulators. In several other kinds of exocrine glands, such as parotid gland, salivary gland, and pancreatic gland, it is also known that these calcium oscillations are essential for basic secretions (5, 21, 36, 43, 46) . We think that flagellin likely enhances the ACh-activated signaling pathway through Ca and NOS but does not activate the same pathway. Our study showed that flagellin alone did not generate any ionic currents (Fig. 1D) . Additionally, the intracellular calcium assays revealed that flagellin did not increase the [Ca 2ϩ ] i after the stimulation by 30 nM of ACh (Fig. 2) . Without any increase in [Ca 2ϩ ] i , flagellin (0.5-1.0 g/ml) significantly potentiated both the ionic currents (Fig. 1A) and NO synthesis (Fig. 6G) induced by 30 nM of ACh. These findings strongly suggested that flagellin increased the sensitivity of NOS to Ca 2ϩ , which was properly raised by low doses of ACh. When the cells were stimulated by very high concentrations of ACh, they were desensitized, and we think that flagellin could no longer show any potentiation (Fig. 1G) .
Concerning the relationship between flagellin/TLR5 and NO/cGMP/cGK signaling, there are some useful reports describing the importance of iNOS. Mizel and coworkers (30) reported that flagellin induced NO synthesis via an increase in iNOS mRNA and activation of the iNOS promoter in HeNC2 cells, a murine macrophage cell line. They mentioned that this flagellin-induced upregulation of iNOS required signaling via heteromeric TLR5/TLR4 complexes (30) . Kumer and coworkers (26) reported that flagellin enhanced bacterial clearance and significantly improved the disease outcome via an upregulation of iNOS in the C57BL/6 mouse model of P. aeruginosa keratitis. Unlike these two reports, we do not think iNOS was involved in the flagellin-induced rapid potentiation of basal secretion investigated here. As shown in Fig. 5, A, B , C, and F, the iNOS inhibitor L-NIL did not abolish the flagellin-induced potentiating effects although the nonspecific NOS inhibitors L-NAME and L-NMMA did. Additionally, the response time seems be too short to upregulate iNOS transcription because our studies were focused only on the very rapid (milliseconds to seconds) effects of flagellin/TLR5 on triggered-ionic currents. These findings suggested that constitutive NOS, not iNOS, should be involved in the flagellin/TLR5-mediated potentiation of tracheal gland secretion. However, we cannot exclude the possibility that iNOS has additively important roles in the potentiation of airway serous secretion at a much later phase in airway chronic inflammation. Fig. 7 . Drawing delineating the proposed pathways of flagellin/TLR5 signaling in electrolyte secretion in tracheal submucosal gland acinar cells. In the airways with chronic airway Pseudomonas aeruginosa (P. aeruginosa) infection, if flagellin can reach both around the submucosal glands and the lumen of the gland ducts, TLR5 is likely to be activated and show potentiating effects on Cl Ϫ secretion induced by physiologically relevant low doses of ACh from vagal nerve ending in a NO/cGMP/cGK-dependent manner. Thus we believe that, not only LPS/TLR4 signaling, but also flagellin/TLR5 signaling is likely involved in hypersecretion, resulting in exacerbations in chronic inflammatory airway diseases with repeated P. aeruginosa infection.
Finally, there remains the clinical significance of flagellin/ TLR5 in chronic airway P. aeruginosa infection. Differing from a report describing the importance of heteromeric TLR5/ TLR4 complexes (30), our present study showed that the cross reaction between flagellin and TLR4 or between LPS and TLR5 was not involved in these potentiations (Fig. 3) . We believe that, not only LPS/TLR4 signaling, but also flagellin/ TLR5 signaling is likely involved in hypersecretion, resulting in exacerbations in chronic inflammatory airway diseases with repeated P. aeruginosa infection (Fig. 7) . If our data can be recapitulated in vivo, we think that these findings will advance the field in the future. Furthermore, it will be complementary if tracheal submucosal glands could be treated with wild-type P. aeruginosa compared with an isogenic flagellin-deficient strain (such as PAK/fliC) P. aeruginosa and show the significance of flagellin in airway secretion. This will provide some in vivo relevance to the potential role of flagellin in chronic airway diseases.
In conclusion, we revealed a novel potentiating effect of flagellin/TLR5 signaling in airway serous secretion that was independent of LPS/TLR4 signaling. These findings suggest that pathogens with these ligands for TLRs are able to cause hypersecretion in the airway even in cases of colonization. We believe that, not only TLR4, but also TLR5 could be a new therapeutic candidate for controlling airway secretion in chronic inflammatory airway diseases, such as COPD and even cystic fibrosis.
